GlassScriptPhysician profile
Sara Khodor
NPI 1720440068
$3,847.20
in general payments reported to CMS, 2019-2025
23 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $841 · 2020: $441 · 2021: $799 · 2022: $953 · 2023: $606 · 2024: $24.51 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,128.01 | 2019-2022 | |
| Medtronic, INC. | $566.32 | 2021-2023 | Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $365.48 | 2019-2022 | |
| Boston Scientific Corporation | $334.85 | 2020-2025 | Synergy, Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $253.76 | 2019-2020 | |
| Astellas Pharma US INC | $198.00 | 2019 | |
| Inari Medical, INC. | $195.28 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.10 | 2019-2025 | Lifevest |
| Shockwave Medical, INC | $148.85 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cathworks, INC. | $84.12 | 2023 | Ffrangio |
| Penumbra, INC. | $79.77 | 2022-2023 | Indigo System |
| Actelion Pharmaceuticals US, INC. | $70.55 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $29.52 | 2021 | |
| Terumo Medical Corporation | $29.00 | 2023 | Glidesheath Slender, Angio-Seal |
| Cardiva Medical, INC. | $27.43 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $27.00 | 2020 | |
| Abiomed | $25.59 | 2023 | Impella |
| Edwards Lifesciences Corporation | $24.86 | 2025 | |
| Cvrx, INC. | $24.51 | 2024 | Barostim Neo System |
| Teleflex LLC | $18.13 | 2022 | |
| Pfizer INC. | $18.10 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.01 | 2019 | |
| Amarin Pharma, INC. | $13.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Khodor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.